Diabetic muscle infarction after simultaneous pancreas-kidney transplant

Spiros Delis, Gaetano Ciancio, Victor Casillas, Jose Figueiro, Alvaro Garcia, Joshua Miller, George W Burke

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Diabetic muscle infarction (DMI) is a rare entity that occurs in patients with long-standing type 1 insulin dependent diabetes mellitus (IDDM). We describe DMI occurring on an average of 5 months after SPK in four patients with IDDM and end stage renal disease (ESRD). These patients had evidence of other long-term diabetic complications including retinopathy and neuropathy, as well as microangiopathy and hypercoagulability, both of which are pre-disposing factors for DMI. The etiology of DMI is not well understood. Despite establishment of normoglycemia after kidney-pancreas transplantation, DMI may occur as a result of tissue damage/fragility secondary to the pre-existing long-term labile glycemic control and hypertension. This may be exacerbated by the pro-coagulant effects of the calcineurin-inhibitors and the use of steroids as part of the immunosuppressive regimen.

Original languageEnglish
Pages (from-to)295-300
Number of pages6
JournalClinical Transplantation
Volume16
Issue number4
DOIs
StatePublished - Aug 12 2002

Fingerprint

Infarction
Pancreas
Transplants
Kidney
Muscles
Type 1 Diabetes Mellitus
Pancreas Transplantation
Coagulants
Thrombophilia
Diabetes Complications
Immunosuppressive Agents
Kidney Transplantation
Chronic Kidney Failure
Steroids
Insulin
Hypertension

Keywords

  • Diabetic muscle infarction
  • Kidney tranplant
  • Simultaneous pancreas

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Diabetic muscle infarction after simultaneous pancreas-kidney transplant. / Delis, Spiros; Ciancio, Gaetano; Casillas, Victor; Figueiro, Jose; Garcia, Alvaro; Miller, Joshua; Burke, George W.

In: Clinical Transplantation, Vol. 16, No. 4, 12.08.2002, p. 295-300.

Research output: Contribution to journalArticle

Delis, Spiros ; Ciancio, Gaetano ; Casillas, Victor ; Figueiro, Jose ; Garcia, Alvaro ; Miller, Joshua ; Burke, George W. / Diabetic muscle infarction after simultaneous pancreas-kidney transplant. In: Clinical Transplantation. 2002 ; Vol. 16, No. 4. pp. 295-300.
@article{c22aa270f29d4fccb28d87dcfd049053,
title = "Diabetic muscle infarction after simultaneous pancreas-kidney transplant",
abstract = "Diabetic muscle infarction (DMI) is a rare entity that occurs in patients with long-standing type 1 insulin dependent diabetes mellitus (IDDM). We describe DMI occurring on an average of 5 months after SPK in four patients with IDDM and end stage renal disease (ESRD). These patients had evidence of other long-term diabetic complications including retinopathy and neuropathy, as well as microangiopathy and hypercoagulability, both of which are pre-disposing factors for DMI. The etiology of DMI is not well understood. Despite establishment of normoglycemia after kidney-pancreas transplantation, DMI may occur as a result of tissue damage/fragility secondary to the pre-existing long-term labile glycemic control and hypertension. This may be exacerbated by the pro-coagulant effects of the calcineurin-inhibitors and the use of steroids as part of the immunosuppressive regimen.",
keywords = "Diabetic muscle infarction, Kidney tranplant, Simultaneous pancreas",
author = "Spiros Delis and Gaetano Ciancio and Victor Casillas and Jose Figueiro and Alvaro Garcia and Joshua Miller and Burke, {George W}",
year = "2002",
month = "8",
day = "12",
doi = "10.1034/j.1399-0012.2002.01151.x",
language = "English",
volume = "16",
pages = "295--300",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Diabetic muscle infarction after simultaneous pancreas-kidney transplant

AU - Delis, Spiros

AU - Ciancio, Gaetano

AU - Casillas, Victor

AU - Figueiro, Jose

AU - Garcia, Alvaro

AU - Miller, Joshua

AU - Burke, George W

PY - 2002/8/12

Y1 - 2002/8/12

N2 - Diabetic muscle infarction (DMI) is a rare entity that occurs in patients with long-standing type 1 insulin dependent diabetes mellitus (IDDM). We describe DMI occurring on an average of 5 months after SPK in four patients with IDDM and end stage renal disease (ESRD). These patients had evidence of other long-term diabetic complications including retinopathy and neuropathy, as well as microangiopathy and hypercoagulability, both of which are pre-disposing factors for DMI. The etiology of DMI is not well understood. Despite establishment of normoglycemia after kidney-pancreas transplantation, DMI may occur as a result of tissue damage/fragility secondary to the pre-existing long-term labile glycemic control and hypertension. This may be exacerbated by the pro-coagulant effects of the calcineurin-inhibitors and the use of steroids as part of the immunosuppressive regimen.

AB - Diabetic muscle infarction (DMI) is a rare entity that occurs in patients with long-standing type 1 insulin dependent diabetes mellitus (IDDM). We describe DMI occurring on an average of 5 months after SPK in four patients with IDDM and end stage renal disease (ESRD). These patients had evidence of other long-term diabetic complications including retinopathy and neuropathy, as well as microangiopathy and hypercoagulability, both of which are pre-disposing factors for DMI. The etiology of DMI is not well understood. Despite establishment of normoglycemia after kidney-pancreas transplantation, DMI may occur as a result of tissue damage/fragility secondary to the pre-existing long-term labile glycemic control and hypertension. This may be exacerbated by the pro-coagulant effects of the calcineurin-inhibitors and the use of steroids as part of the immunosuppressive regimen.

KW - Diabetic muscle infarction

KW - Kidney tranplant

KW - Simultaneous pancreas

UR - http://www.scopus.com/inward/record.url?scp=0036020623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036020623&partnerID=8YFLogxK

U2 - 10.1034/j.1399-0012.2002.01151.x

DO - 10.1034/j.1399-0012.2002.01151.x

M3 - Article

VL - 16

SP - 295

EP - 300

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 4

ER -